Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Shares Issued (2023 - 2025)

Historic Shares Issued for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $48.3 million.

  • CG Oncology's Shares Issued changed N/A to $48.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $272.1 million, marking a year-over-year decrease of 3309.08%. This contributed to the annual value of $406.4 million for FY2024, which is 1942017.29% up from last year.
  • As of Q3 2025, CG Oncology's Shares Issued stood at $48.3 million.
  • CG Oncology's Shares Issued's 5-year high stood at $406.4 million during Q1 2024, with a 5-year trough of $19000.0 in Q2 2025.
  • Moreover, its 3-year median value for Shares Issued was $682000.0 (2025), whereas its average is $75.6 million.
  • Per our database at Business Quant, CG Oncology's Shares Issued soared by 59756176.47% in 2024 and then tumbled by 9983.22% in 2025.
  • CG Oncology's Shares Issued (Quarter) stood at $262000.0 in 2023, then skyrocketed by 85052.67% to $223.1 million in 2024, then plummeted by 78.35% to $48.3 million in 2025.
  • Its last three reported values are $48.3 million in Q3 2025, $19000.0 for Q2 2025, and $682000.0 during Q1 2025.